Alumis (ALMS) Cash from Investing Activities (2023 - 2025)

Alumis (ALMS) reported Cash from Investing Activities of $95.0 million for Q4 2025, up 206.99% year-over-year from $31.0 million in Q4 2024, and up 295.29% quarter-over-quarter from $24.0 million in Q3 2025.

Alumis (ALMS) Cash from Investing Activities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Cash from Investing Activities data on file, last reported at $95.0 million in Q4 2025.

  • Cash from Investing Activities for Q4 2025 came in at $95.0 million, up 206.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $287.9 million (up 352.99% YoY), and the FY2025 annual result was $287.9 million, up 352.99% from the prior year.
  • Cash from Investing Activities improved to $95.0 million in Q4 2025 per ALMS's latest filing, from $24.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $129.4 million in Q2 2025 and troughed at -$93.2 million in Q3 2024.
  • A 3-year average of $17.8 million and a median of $15.8 million in 2023 frame the typical range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 846.86% in 2024 and fell as far as 1330.06% in 2024.
  • A 3-year view of Cash from Investing Activities shows it stood at -$4.1 million in 2023, then jumped by 846.86% to $31.0 million in 2024, then soared by 206.99% to $95.0 million in 2025.
  • Business Quant data shows ALMS's Cash from Investing Activities at $95.0 million in Q4 2025, $24.0 million in Q3 2025, and $129.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Alumis 1.99 Bn 1.90 Bn - 95.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 95.01 Mn
Dec 31, 2025 95.01 Mn
Sep 30, 2025 24.04 Mn
Sep 30, 2025 24.04 Mn
Jun 30, 2025 129.40 Mn
Jun 30, 2025 129.40 Mn
Mar 31, 2025 39.43 Mn
Mar 31, 2025 39.43 Mn
Dec 31, 2024 30.95 Mn
Dec 31, 2024 30.95 Mn
Sep 30, 2024 -93.19 Mn
Sep 30, 2024 -93.19 Mn
Jun 30, 2024 -32.74 Mn
Jun 30, 2024 -32.74 Mn
Mar 31, 2024 -18.81 Mn
Mar 31, 2024 -18.81 Mn
Dec 31, 2023 -4.14 Mn
Dec 31, 2023 -4.14 Mn
Sep 30, 2023 7.58 Mn
Sep 30, 2023 7.58 Mn